Magazine article from our research archive:

Olopatadine indications expanded to treat redness

NEW YORK-The FDA expanded indications for olopatadine HCI 0.1% ophthalmic solution (Patanol, Alcon) in March to include treatment of the redness that is a manifestation of allergic conjunctivitis.

Ophthalmologists and allergists alike are praising the drug's effectiveness in treating a condition that affects 20 million Americans annually.

"Olopatadine is a `home run' compared with other commercially available anti-allergy medications. It is extremely effective for all the signs and symptoms of allergic conjunctivitis-not only itching, but redness as well. Because the drug is so comfortable to use, patients commonly request it by name," explained Peter D'Arienzo, MD, clinical assistant ...

Related newspaper, magazine, and journal articles:

See all results. Or, try our Advanced Search.

Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 60 million articles! Access over 3,500 publications with a FREE trial!